arBtrage CAPITALIZING MARKETS checking… Sign in Sign up

Axsome Therapeutics, Inc.

AXSM Health Care Biotechnology: Pharmaceutical Preparations
$232.32
▲ +0.4% Today
as of Jun 7, 07:09 ET
Last 30 days +25.58% Apr 28 → Jun 05
$179.79 $194.87 $209.96 $225.05 $240.13 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$231.21
High
$242.41
Low
$228.24
Volume
$973,239
Avg Vol
$631,976
Mkt Cap
$12.0B
P/E (TTM)
Beta
52w High
$242.41
52w Low
$96.09
Div Yield
Shares Out
$51M

Overview

52-week range
$96
$242
93% of range
Avg surprise (last 2)
-5.9%
Avg reaction (last 2)
+6.1%
100% positive
Latest IV / EM
42%
EM ±5.9% · $230 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.67$-1.45$-1.23$-1.02$-0.80 Actual $-1.54Actual $-1.32Actual $-1.44Actual $-1.67Actual $-1.34Actual $-0.80Est $-1.26Actual $-0.97Actual $-0.94Actual $-1.26Est $-0.85 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-79M$-72M$-64M$-57M$-50M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Mon May 4, 2026Mar/2026 $-1.26 $-0.85 -48.2% -57.5% +8.3% earnings
Tue Sep 30, 2025Sep 2025 $-0.94 financials
Mon Jun 30, 2025Jun 2025 $-0.97 financials
Mon May 5, 2025Mar/2025 $-0.80 $-1.26 +36.5% +3.8% earnings
Mon Sep 30, 2024Sep 2024 $-1.34 financials
Sun Jun 30, 2024Jun 2024 $-1.67 financials
Sun Mar 31, 2024Mar 2024 $-1.44 financials
Sat Sep 30, 2023Sep 2023 $-1.32 financials
Fri Jun 30, 2023Jun 2023 $-1.54 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
Cost of revenue
Gross profit
Operating income$-63M$-46M$-37M$-57M$-63M$-78M
Net income$-65M$-47M$-48M$-59M$-65M$-79M
EPS (diluted)$-1.26$-0.94$-0.97$-1.22$-1.34$-1.67

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$305M$323M$325M$303M$301M$315M$327M$316M
Inventory$32M$28M$24M$18M$16M$16M$14M$15M
Total current assets$611M$589M$565M$537M$495M$485M$479M$463M
Total assets$714M$690M$669M$640M$597M$568M$561M$548M
Long-term debt$118M$118M$118M$118M$181M$181M$180M$179M
Total liabilities$659M$602M$596M$567M$543M$511M$469M$445M
Total equity$55M$88M$74M$73M$53M$57M$93M$103M

Implied volatility — last 90 days

37%39%42%44%47% Jun 07 — IV 42% · EM ±5.9%

Sector peers

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.